Trinity Biotech plc (TRIB)
TRIB trades on Nasdaq in Health Care, Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.30
-3.96% on the day
Market cap
$5.1M
Nano cap
Revenue · 2024
$61.6M
No prior year to compare
Net income · 2024
-$31.8M
-51.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/0001178913-25-001835-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2024-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | TRIB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Country | Ireland |
| IPO year | 1992 |
| SEC CIK | 0000888721 |
| SEC industry code | In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | L2 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $61.6M |
| Net income | -$31.8M |
| Operating income | Not in SEC XBRL data |
| Net margin | -51.6% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2026-08-28 |
| Latest annual report | 20-F | 2026-04-30 |
| Latest quarterly / interim | 6-K | 2026-10-05 |
Source: SEC EDGAR submissions feed, 500 recent filings. All filings on EDGAR.
Peers in Biotechnology: In Vitro & In Vivo Diagnostic Substances
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc. | $1.75 | -1.69% | $5.2M |
| VNRX | VolitionRX Limited | $0.1847 | -9.06% | $5.6M |
| QCLS | Q/C Technologies Inc. | $0.5465 | -5.79% | $4.5M |
| BMRA | Biomerica Inc. | $1.85 | +0.82% | $8.5M |
| VRAX | Virax Biolabs Group Limited | $1.74 | -6.05% | $2.3M |
| IMDX | Insight Molecular Diagnostics Inc. | $2.99 | -5.68% | $97.8M |
| ICCC | ImmuCell Corporation | $10.79 | +12.40% | $98.0M |
| MYGN | Myriad Genetics Inc. | $4.08 | -2.86% | $390.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier